Xuefeng Yu

A Nomogram for Predicting the Risk of CKD Based on Cardiometabolic Risk Factors

Xiaoyu Meng, P. Yu, Ranran Kan, 2023, International journal of general medicine.

CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

H. Rodbard, T. Battelino, P. Topsever, 2024, Cardiovascular diabetology.

Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies

S. Shao, Qinqin Xu, Xuefeng Yu, 2024, Medicinal research reviews.

Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway

Xiaoyu Meng, Huajie Zou, Li Huang, 2024, Journal of neuroinflammation.

Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review

Xiaoli Shi, Yan Yang, Xuefeng Yu, 2024, Frontiers in Endocrinology.

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes

Xiaoli Shi, Shujun Zhang, Lei Xie, 2024, Journal of diabetes investigation.